The use of omega-3 fatty acids in mental illness. - Wikidata - wikimedia - TriplyDB

The use of omega-3 fatty acids in mental illness.

The use of omega-3 fatty acids in mental illness.

http://www.wikidata.org/entity/Q37937303

about

Mechanism of the modulation of BK potassium channel complexes with different auxiliary subunit compositions by the omega-3 fatty acid DHA.Omega-3 fatty acids: An update emphasizing clinical use.

P2860

Q36712653-6BDE02A4-EFBD-4AA3-B5AF-2E151FBF8C78 Q37475555-A5662CD2-1732-4948-BA47-C1827B3AABE5

P2860

The use of omega-3 fatty acids in mental illness.

http://www.wikidata.org/entity/Q37937303

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The use of omega-3 fatty acids in mental illness.

@en

The use of omega-3 fatty acids in mental illness.

@nl

type

label

The use of omega-3 fatty acids in mental illness.

@en

The use of omega-3 fatty acids in mental illness.

@nl

prefLabel

The use of omega-3 fatty acids in mental illness.

@en

The use of omega-3 fatty acids in mental illness.

@nl

P1433

Q37937303-281E88C3-48BA-416F-959F-BF78CD065DB3

P1476

Q37937303-96911DC8-B4EF-4405-8F40-D59447EE35CE

P2093

Q37937303-E2C2ED1A-A985-4EEB-AAEB-4AA679BCE2BE

Q37937303-E6D65872-F53C-447D-B7DF-85336DEBE45A

P2860

Q37937303-009551D9-66AA-44B6-95AC-36F3BA41E968

Q37937303-022CE2A1-3C68-46D6-BD4D-16352BFAE91C

Q37937303-09DB022F-196C-4CA0-A27D-C658B65BD560

Q37937303-0BB8723B-8219-4C18-9EA6-A6DEE3DF1069

Q37937303-0BE6874E-7C0A-4A90-ACF1-E6AC0037A35B

Q37937303-0C5C1DC7-3E91-4EB5-8440-764111DEE950

Q37937303-0DE0D441-BF50-4EC5-9473-6BBE2A983568

Q37937303-0E4E29DB-415C-4C29-9C1A-FAC651CF7C70

Q37937303-118FC4A9-6C2E-43DA-915B-76DF7F15747B

Q37937303-137CF1FC-98FE-4FF0-BAC4-366B5E2E9FD5

P304

Q37937303-07C6BA8F-4180-40B8-AAC2-F1568B408C7F

P31

Q37937303-B9CB4F61-A815-45BD-A20F-361280C1B47B

P356

Q37937303-F9417896-7E8A-4604-A7C9-BB0AF28A541F

P433

Q37937303-DACAC26E-76CC-4546-BF46-BA3CD0570896

P478

Q37937303-0B54A5C1-BF6B-45A9-8625-1CA6BE39D950

P577

Q37937303-0C1A2234-42A9-40D8-95DD-F9A6469252FC

P5875

Q37937303-D7A84AE7-B568-4BFE-9B9A-225367AD0C64

P698

Q37937303-5D7A0FAE-2C9D-4AF5-8B64-AA702204CB44

P921

Q37937303-92E260CE-EF1B-41CD-807D-B36ADB8D14C8

P356

0897190011422876

P1433

Journal of Pharmacy Practice

P1476

The use of omega-3 fatty acids in mental illness.

@en

P2093

Ashley T Tewksbury

http://www.w3.org/2001/XMLSchema#string

Jessica L Gören

http://www.w3.org/2001/XMLSchema#string

P2860

Qualitative or Quantitative Differences Between Asperger’s Disorder and Autism? Historical Considerations

Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

Clinical potential of omega-3 fatty acids in the treatment of schizophrenia

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

P304

452-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0897190011422876

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51664106

http://www.w3.org/2001/XMLSchema#string

P698

21940602

http://www.w3.org/2001/XMLSchema#string

P921